Clinical Trials Directory

Trials / Unknown

UnknownNCT05484232

Outcomes of Early Laparoscopic Cholecystectomy in Cases of Acute Cholecystitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Laparoscopic cholecystectomy is the most common laparoscopic surgery performed in the world. The initial treatment of acute calculus cholecystitis includes GIT rest, intravenous fluid, correction of electrolyte imbalance from repeated vomiting, good analgesia, and intravenous antibiotics. Following this treatment, patients with uncomplicated disease are managed on outpatient basis and are called for elective laparoscopic cholecystectomy after a period of 6-8 weeks. Elective laparoscopic cholecystectomy has become the gold standard for treatment of symptomatic gallstones. However, in the early days, acute cholecystitis was a contraindication of laparoscopic cholecystectomy, and patients with acute cholecystitis were managed conservatively and discharged for re-admission in order to have elective surgery performed for the definitive treatment. Early laparoscopic cholecystectomy, within 72 hours of presentation,has been advocated because of shorter hospital stay, decreased financial costs and reduced readmission rates. Previously cited reasons against early laparoscopic cholecystectomy include the increased technical difficulties, increased risk of conversion to an open procedure (6-35 % in some studies) and increased risks of biliary complications such as bile leaks and common bile duct (CBD) injuries when operating on an inflamed gallbladder with edematous planes and distorted anatomy.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic CholecystectomyEarly laparoscopic cholecystectomy in patients with acute calcular cholecystitis

Timeline

Start date
2022-08-01
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2022-08-02
Last updated
2022-08-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05484232. Inclusion in this directory is not an endorsement.